Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-0725-2026

Enterix, Inc. recalls InSure ONE Fecal Immunochemical Test. Labeled as follows: 1. Insure ONE POL Patient…

Enterix, Inc.Edison, NJ, United StatesReported Dec 10, 2025 · 7 months ago
Legal News Analyst ·

Reason for recall

InSure ONE failed sensitivity testing when used with Test Card Lot T241102, which may result in false negative results.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

InSure ONE Fecal Immunochemical Test. Labeled as follows: 1. Insure ONE POL Patient Kit - 10 pack. Model Number: 90010. 2. Insure ONE POL Patient Kit - 25 Pack. Model Number: 90025. 3. InSure ONE POL Combo Pack. Model Number: 90030. InSure ONE is a fecal immunochemical test (FIT) that qualitatively detects human hemoglobin from blood in fecal samples.

Lot / code information

Model
90010
GTIN
10850093003313; All lots produced from 7/23/2025-9/12/2025 with Test card
Lot #
TT241102. 2
Model
90025
GTIN
20850093003310; All lots produced from 7/23/2025-9/12/2025 with Test card
Lot #
TT241102. 3
Model
90030
GTIN
00850093003279; All lots produced from 7/23/2025-9/12/2025 with Test card
Lot #
TT241102

What the firm is doing

Consignees were initially sent an email as notification of the recall on about 09/17/2025, which was followed by a formal recall notification letter on about 09/23/2025. Consignees were instructed to immediately examine inventory and quarantine any affected units, notify customers if affected further distributed, and for those patients that have already been tested using an InSure ONE test kit that has been identified as part of the scope of this recall be retested. Once an inventory count has been received by Enterix, they will provide RMA and courier information so the recalled product can be returned for sorting and destruction.

DistributionShow details

Worldwide - US Nationwide distribution in the states of California, Florida, Georgia, Illinois, Indiana, Kentucky, Massachusetts, Nevada, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Texas, Washington, West Virginia and the country of Philippines.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls